000 01296 a2200385 4500
005 20250515210940.0
264 0 _c20100525
008 201005s 0 0 eng d
022 _a1944-7930
040 _aNLM
_beng
_cNLM
100 1 _aCapdevila, Jaume
245 0 0 _aNew approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
_h[electronic resource]
260 _bDiscovery medicine
_cFeb 2010
300 _a153-62 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCarcinoma
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
_xtherapeutic use
650 0 4 _aMedical Oncology
650 0 4 _aModels, Biological
650 0 4 _aPlacebos
650 0 4 _aPrognosis
650 0 4 _aSignal Transduction
650 0 4 _aThyroid Neoplasms
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aArgiles, Guillem
700 1 _aRodriguez-Frexinos, Victor
700 1 _aNuñez, Isaac
700 1 _aTabernero, Josep
773 0 _tDiscovery medicine
_gvol. 9
_gno. 45
_gp. 153-62
999 _c19561674
_d19561674